Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.850
+0.010 (1.21%)
Jul 22, 2024, 10:14 AM EDT - Market open
Lucid Diagnostics Employees
Lucid Diagnostics had 70 employees as of December 31, 2023. The number of employees decreased by 4 or -5.41% compared to the previous year.
Employees
70
Change (1Y)
-4
Growth (1Y)
-5.41%
Revenue / Employee
$42,614
Profits / Employee
-$778,957
Market Cap
45.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| NeueHealth | 1,252 |
| Apyx Medical | 252 |
| NextCure | 82 |
| DURECT | 58 |
| Envoy Medical | 34 |
| Matinas BioPharma Holdings | 32 |
| CalciMedica | 12 |
| Marker Therapeutics | 8 |
LUCD News
- 11 days ago - Lucid Diagnostics Launches New Corporate Website - PRNewsWire
- 20 days ago - Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population - PRNewsWire
- 5 weeks ago - 4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing - PRNewsWire
- 2 months ago - PAVmed Provides Business Update and First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall - PRNewsWire
- 2 months ago - Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors - PRNewsWire
- 2 months ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - PRNewsWire